[1]
N. Akbari i M. Saadat, „No Evidence for an Association Between the Chemokine Receptor 5 Δ32 Polymorphism and Multiple Sclerosis Susceptibility: A Meta-Analysis: CCR5-Δ32 and MS, meta-analysis “, Scr Med, vol 56, izd. 1, str. 105–115, Feb. 2025, doi: 10.5937/scriptamed56-54562.